Corpus Intelligence IC Memo — GRACE HOSPITAL 2026-04-26 14:04 UTC
IC Memo — GRACE HOSPITAL
Investment Committee Memorandum | OH | 17 beds | Grade D | EBITDA uplift $429K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GRACE HOSPITAL

CCN 362015 | CUYAHOGA, OH | 17 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

GRACE HOSPITAL is a 17-bed under-performing / distressed in CUYAHOGA, OH with $5.7M in net patient revenue and a -50.7% operating margin. The hospital serves a payer mix of 49.0% Medicare, 8.6% Medicaid, and 42.4% commercial.

Thesis: Turnaround. Our ML models identify $429K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -50.7% to -43.2% (+756bps).

Net Revenue HCRIS$5.7M
Current EBITDA COMPUTED$-2.9M
Operating Margin COMPUTED-50.7%
Occupancy HCRIS44.1%
Revenue / Bed COMPUTED$334K
Net-to-Gross HCRIS43.5%
Distress Probability ML54.0%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
59
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -50.7% places it below the state median. Among 59 size-comparable peers (8-34 beds), the median margin is -3.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-34), prioritizing same-state peers. 59 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GRACE HOSPITAL (Target)OH17$5.7M-50.7%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
JOINT TOWNSHIP DISTRICT MEMORIOH33$95.6M9.3%
FULTON COUNTY HEALTH CENTEROH25$95.2M-7.4%
MEMORIAL HOSPITALOH31$79.9M4.6%
DEFIANCE HOSPITAL INC.OH25$78.6M16.7%
WYANDOT MEMORIAL HOSPITALOH24$74.7M7.4%
SELBY GENERAL HOSPITALOH25$73.3M14.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $429K (756bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$119K+210bp18mo
Denial Rate Reduction12.0%6.5%$118K+207bp12mo
Cost to Collect4.5%2.5%$114K+200bp12mo
A/R Days Reduction5200.0%3800.0%$69K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+17bp6mo

5. EBITDA Bridge

Net Collection Rate
$119K
Denial Rate Reduction
$118K
Cost to Collect
$114K
A/R Days Reduction
$69K
Clean Claim Rate
$10K
Total EBITDA Uplift$429K
Current EBITDA$-2.9M
+ RCM Uplift+$429K
Pro Forma EBITDA$-2.5M
Current Margin-50.7%
Pro Forma Margin-43.2%
WC Released (1x)$218K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.4M$-14.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.4M$-17.6M0.00x-100.0%
Bull Case9.0x11.0x$-4.0M$-17.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.0M$-20.4M0.00x-100.0%
Bear Case11.0x10.0x$-4.9M$-15.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.9M$-18.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
HighElevated distress probabilityModel estimates 54.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 59 hospitals with 8-34 beds
  • Same-state prioritization (n=60)
  • Comp margins: P25=-11.2% / P50=-3.1% / P75=14.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.